Literature DB >> 19390243

Alterations of mitochondrial function in sepsis and critical illness.

Anatole Harrois1, Olivier Huet, Jacques Duranteau.   

Abstract

PURPOSE OF REVIEW: Septic shock is the consequence of a conflict between a pathogenic agent and the immune system of the host. This conflict induces an immune-mediated cytokine storm, with a whole-body inflammatory response often leading to multiple organ failure. Although extensively studied, the pathophysiology of sepsis-associated multiorgan failure remains unknown. One postulated mechanism is changes in mitochondrial function with an inhibition of mitochondrial respiratory chain and a decrease of oxygen utilization. RECENT
FINDINGS: Mitochondrion is a key organelle in supplying energy to the cell according to its metabolic need. Hypoxia and a number of the mediators implicated in sepsis and in the associated systemic inflammatory response have been demonstrated to directly impair mitochondrial function. A large body of evidence supports a key role of the peroxynitrite, which can react with most of the components of the electron transport chain, in the mitochondrial dysfunction.
SUMMARY: A pivotal role is suggested for mitochondrial dysfunction during the occurrence of multiorgan failure. Understanding the precise effect of sepsis on the mitochondrial function and the involvement of mitochondria in the development of multiple organ failure is fundamental. More human studies are thus necessary to clarify the mitochondrial dysfunction in the various phases of sepsis (early and late phase) before testing therapeutic strategies targeting mitochondria.

Entities:  

Mesh:

Year:  2009        PMID: 19390243     DOI: 10.1097/ACO.0b013e328328d1cc

Source DB:  PubMed          Journal:  Curr Opin Anaesthesiol        ISSN: 0952-7907            Impact factor:   2.706


  33 in total

1.  Mitochondrial Ca²+ and ROS take center stage to orchestrate TNF-α-mediated inflammatory responses.

Authors:  Laura A Dada; Jacob I Sznajder
Journal:  J Clin Invest       Date:  2011-04-25       Impact factor: 14.808

2.  Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury.

Authors:  Mohammad Naimul Islam; Shonit R Das; Memet T Emin; Michelle Wei; Li Sun; Kristin Westphalen; David J Rowlands; Sadiqa K Quadri; Sunita Bhattacharya; Jahar Bhattacharya
Journal:  Nat Med       Date:  2012-04-15       Impact factor: 53.440

3.  Coenzyme Q10 levels are low and associated with increased mortality in post-cardiac arrest patients.

Authors:  Michael N Cocchi; Brandon Giberson; Katherine Berg; Justin D Salciccioli; Ali Naini; Catherine Buettner; Praveen Akuthota; Shiva Gautam; Michael W Donnino
Journal:  Resuscitation       Date:  2012-03-28       Impact factor: 5.262

4.  Overexpressed UCP2 regulates mitochondrial flashes and reverses lipopolysaccharide-induced cardiomyocytes injury.

Authors:  Wenbo Chen; Shiyu Luo; Peng Xie; Tingting Hou; Tian Yu; Xiaoyun Fu
Journal:  Am J Transl Res       Date:  2018-05-15       Impact factor: 4.060

Review 5.  Pathophysiological roles of peroxynitrite in circulatory shock.

Authors:  Csaba Szabó; Katalin Módis
Journal:  Shock       Date:  2010-09       Impact factor: 3.454

6.  Mitochondrial dysfunction in peripheral blood mononuclear cells in pediatric septic shock.

Authors:  Scott L Weiss; Mary A Selak; Florin Tuluc; Jose Perales Villarroel; Vinay M Nadkarni; Clifford S Deutschman; Lance B Becker
Journal:  Pediatr Crit Care Med       Date:  2015-01       Impact factor: 3.624

7.  Mitochondrial approaches to protect against cardiac ischemia and reperfusion injury.

Authors:  Amadou K S Camara; Martin Bienengraeber; David F Stowe
Journal:  Front Physiol       Date:  2011-04-12       Impact factor: 4.566

8.  Complement dependency of cardiomyocyte release of mediators during sepsis.

Authors:  Gelareh Atefi; Firas S Zetoune; Todd J Herron; José Jalife; Markus Bosmann; Rami Al-Aref; J Vidya Sarma; Peter A Ward
Journal:  FASEB J       Date:  2011-04-08       Impact factor: 5.191

9.  Pharmacometabolomics of l-carnitine treatment response phenotypes in patients with septic shock.

Authors:  Michael A Puskarich; Michael A Finkel; Alla Karnovsky; Alan E Jones; Julie Trexel; Brooke N Harris; Kathleen A Stringer
Journal:  Ann Am Thorac Soc       Date:  2015-01

Review 10.  Selective iNOS inhibition for the treatment of sepsis-induced acute kidney injury.

Authors:  Suzanne Heemskerk; Rosalinde Masereeuw; Frans G M Russel; Peter Pickkers
Journal:  Nat Rev Nephrol       Date:  2009-09-29       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.